Cases of cervical cancer among women in their 20s are likely to drop by 63 per cent as a result of the HPV vaccine, a new study has suggested.
The research, published in the British Journal of Cancer, indicated that there will be a decline in new diagnoses of the disease over the next decade and a half.
According to scientists from Queen Mary University, taking the vaccine at a younger age can help prevent thousands of new cases in the coming years.
Lead author Professor Jack Cuzick said that the latest data is the "most realistic estimate" of the impact of the HPV jab.
In December 2009, another study in the British Journal of Cancer suggested that women from poorer backgrounds are more likely to develop cervical cancer than their more well-off counterparts because they tend to have sex at a younger age.
Having sex at an early age can almost double the risk of developing cervical cancer, the research said.